SETD2 抗体
(SET Domain Containing 2 (SETD2))
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SETD2 抗体 (AA 2054-2245) | 人 | 小鼠 Monoclonal |
|
|
|
| SETD2 抗体 (N-Term) | 人, 大鼠, 犬 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (AA 323-372) | 人, 小鼠, 大鼠, 犬, 马, Cow | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (N-Term) | 人, 大鼠, 犬, 马 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (N-Term) (PE) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (N-Term) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (N-Term) (APC) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (N-Term) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (N-Term) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (AA 1787-2144) | 人 | 小鼠 Monoclonal |
|
|
|
| SETD2 抗体 (AA 1787-2144) | 人 | 小鼠 Monoclonal |
|
|
|
| SETD2 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (AA 2431-2442) | 人 | 兔 Polyclonal |
|
|
|
| SETD2 抗体 (AA 2475-2564) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Recombinant SETD2 抗体 (Sortase,His tag,AVI tag) | 人 | 兔 Monoclonal |
|
|
|
| Recombinant SETD2 抗体 (Sortase,His tag,AVI tag) | 人 | 兔 Monoclonal |
|
|
Primary Antibody
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4G11E6
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 2054-2245
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人, 大鼠, 犬
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
1 reference - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB2780
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 21-50, N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠, 犬, 马, Cow
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 323-372
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人, 大鼠, 犬, 马
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1C4
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 1787-2144
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1E1
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 1787-2144
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- ICC (Immunocytochemistry: 所列应用)
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 2431-2442
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 2475-2564
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- Sortase,His tag,AVI tag
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- Sortase,His tag,AVI tag
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Latest Publications for our SETD2 抗体
: "HnRNPL inhibits the osteogenic differentiation of PDLCs stimulated by SrCl2 through repressing Setd2." in: Journal of cellular and molecular medicine, Vol. 23, Issue 4, pp. 2667-2677, (2020) (PubMed).
: "H3K36me3-mediated mismatch repair preferentially protects actively transcribed genes from mutation." in: The Journal of biological chemistry, Vol. 293, Issue 20, pp. 7811-7823, (2019) (PubMed).
: "Setd2 is associated with strontium-induced bone regeneration." in: Acta biomaterialia, Vol. 53, pp. 495-505, (2018) (PubMed).
: "Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity." in: Cell, Vol. 170, Issue 3, pp. 492-506.e14, (2017) (PubMed).
: "SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing." in: Nucleic acids research, Vol. 45, Issue 1, pp. 92-105, (2017) (PubMed).
: "Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts." in: Biochimica et biophysica acta. Molecular cell research, Vol. 1864, Issue 4, pp. 697-707, (2017) (PubMed).
: "SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. ..." in: Oncogene, Vol. 34, Issue 46, pp. 5699-708, (2015) (PubMed).
: "Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes." in: Biochemical and biophysical research communications, Vol. 401, Issue 4, pp. 611-7, (2010) (PubMed).
: "Organization of chromatin and histone modifications at a transcription site." in: The Journal of cell biology, Vol. 177, Issue 6, pp. 957-67, (2007) (PubMed).
: "Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase." in: The Journal of biological chemistry, Vol. 280, Issue 42, pp. 35261-71, (2005) (PubMed).
: "H3K36me3-mediated mismatch repair preferentially protects actively transcribed genes from mutation." in: The Journal of biological chemistry, Vol. 293, Issue 20, pp. 7811-7823, (2019) (PubMed).
: "Setd2 is associated with strontium-induced bone regeneration." in: Acta biomaterialia, Vol. 53, pp. 495-505, (2018) (PubMed).
: "Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity." in: Cell, Vol. 170, Issue 3, pp. 492-506.e14, (2017) (PubMed).
: "SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing." in: Nucleic acids research, Vol. 45, Issue 1, pp. 92-105, (2017) (PubMed).
: "Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts." in: Biochimica et biophysica acta. Molecular cell research, Vol. 1864, Issue 4, pp. 697-707, (2017) (PubMed).
: "SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. ..." in: Oncogene, Vol. 34, Issue 46, pp. 5699-708, (2015) (PubMed).
: "Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes." in: Biochemical and biophysical research communications, Vol. 401, Issue 4, pp. 611-7, (2010) (PubMed).
: "Organization of chromatin and histone modifications at a transcription site." in: The Journal of cell biology, Vol. 177, Issue 6, pp. 957-67, (2007) (PubMed).
: "Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase." in: The Journal of biological chemistry, Vol. 280, Issue 42, pp. 35261-71, (2005) (PubMed).
Aliases for SETD2 抗体
SET domain containing 2 (Setd2) 抗体SET domain containing 2 (SETD2) 抗体
HBP231 抗体
HIF-1 抗体
HIP-1 抗体
HYPB 抗体
Kif9 抗体
KMT3A 抗体
p231HBP 抗体
SET2 抗体
您还需要查找其他产品吗？
- SETD1B 抗体
- SETD1A 抗体
- SETBP1 抗体
- SET7 抗体
- SET/TAF-I 抗体
- SET Domain, Bifurcated 1 抗体
- SET Domain Containing (Lysine Methyltransferase) 8 抗体
- SET Binding Factor 2 抗体
- SET and MYND Domain Containing 2a 抗体
- SET and MYND Domain Containing 1 抗体
- Sestrin 2 抗体
- SESTD1 抗体
- SESN3 抗体
- SESN1 抗体
- Seryl-tRNA Synthetase 抗体
- serum/glucocorticoid Regulated Kinase 2 抗体
- serum/glucocorticoid Regulated Kinase 1 抗体
- Serum Amyloid A 抗体
- SERTAD3 抗体
- SERTAD2 抗体
You are here:
